United States · Funded startup

Who invested in Contineum Therapeutics

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 11 months ago

Funding summaryUpdated 26 Oct 2026

$99Mraised across 1 round since 2025, from 1 source

Latest round
Round, $99MDec 2025
Investors
4
See who backed them

The rounds

  1. Dec 2025

Founders and team

From Contineum Therapeutics's own website: 11 on the team.

  • Carmine StengonePresident and Chief Executive Officer
  • Julie IwashitaSenior Vice President, Clinical Operations
  • Matt McKevittVice President, Clinical Development
  • Michael MayberryVice President, Finance
  • Varsha DouradoVice President, Business Development
  • Peter SloverChief Financial Officer
  • John HealyGeneral Counsel & Corporate Secretary
  • Marietta FrancoExecutive Director, Clinical Operations
  • Suhasini KanagalaSenior Director, Regulatory Affairs
  • Wei-Jian PanSenior Director, Clinical Pharmacology
  • Whitney HalladaySenior Director, Clinical Operations

Everyone who backed them

Versant VenturesVC firm1round
Perceptive AdvisorsAsset manager1round
Casdin CapitalVC firm1round
Samsara BioCapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Contineum Therapeutics

Who invested in Contineum Therapeutics?

Contineum Therapeutics's investors include Versant Ventures, Perceptive Advisors, Casdin Capital and Samsara BioCapital.

How much has Contineum Therapeutics raised?

Contineum Therapeutics has raised $99M across 1 round since 2025.

When did Contineum Therapeutics last raise?

Contineum Therapeutics's most recent round was an Undisclosed round of $99M in Dec 2025.

What was Contineum Therapeutics's biggest round?

Its most recent round, $99M in Dec 2025, is also its largest on record.

Who backed Contineum Therapeutics first?

Contineum Therapeutics's first round on record, in Dec 2025, was backed by Versant Ventures, Perceptive Advisors and Casdin Capital and 1 others.

What stage is Contineum Therapeutics at?

Contineum Therapeutics's latest named round is an Undisclosed round, in Dec 2025.

Where is Contineum Therapeutics based?

Contineum Therapeutics is based in the United States.

Companies like Contineum Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.